| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.905 | 24.047 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 7.905 | 101.959 | -68.525 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 7.124 | 127.095 | -88.972 | 1.996 | 10.290 | 4.680 | 1.393 | 5.715 | 1.774 |
| Gross Profit/Loss - EUR | - | 781 | -25.136 | 20.447 | -1.996 | -10.290 | -4.680 | -1.393 | -5.715 | -1.774 |
| Net Profit/Loss - EUR | - | 544 | -28.195 | 22.742 | -1.996 | -10.290 | -4.680 | -1.393 | -5.715 | -1.774 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Viventium Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 48.517 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 3.423 | 90.518 | 20.316 | 18.078 | 5.992 | 153.372 | 152.631 | 152.168 | 151.324 |
| Inventories | - | 1.954 | 0 | 0 | 0 | 0 | 152.159 | 152.631 | 152.168 | 151.318 |
| Receivables | - | 1.336 | 90.551 | 20.316 | 18.078 | 5.992 | 1.213 | 0 | 0 | 7 |
| Cash | - | 133 | -33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | - | 2.770 | -25.469 | -2.260 | -4.213 | -14.423 | -18.783 | -20.235 | -25.888 | -27.518 |
| Social Capital | - | 2.227 | 2.189 | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | 652 | 164.504 | 22.577 | 22.290 | 20.415 | 172.156 | 172.866 | 178.057 | 178.842 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Viventium Med S.r.l.